Connection
Michael Szarek to Propensity Score
This is a "connection" page, showing publications Michael Szarek has written about Propensity Score.
|
|
Connection Strength |
|
 |
|
 |
|
0.040 |
|
|
|
-
Schwartz GG, Gabriel Steg P, Bhatt DL, Bittner VA, Diaz R, Goodman SG, Jukema JW, Kim YU, Li QH, Manvelian G, Pordy R, Sourdille T, White HD, Szarek M. Clinical Efficacy and Safety of Alirocumab After Acute Coronary Syndrome According to Achieved Level of Low-Density Lipoprotein Cholesterol: A Propensity Score-Matched Analysis of the ODYSSEY OUTCOMES Trial. Circulation. 2021 03 16; 143(11):1109-1122.
Score: 0.040